A record 235 million people will need humanitarian assistance and protection next year, a near- 40 per cent increase on 2020 which is “almost entirely from COVID-19”, the UN’s emergency relief chief said on Tuesday.
More
Primary efficacy analysis of the Phase 3 COVE study of mRNA-1273 involving 30,000 participants included 196 cases of COVID-19, of which 30 cases were severe
More
Scientists at the University of Pittsburgh School of Medicine claim they have discovered an antibody which "completely neutralises" coronavirus in what could be a major breakthrough in the hunt for a cure.
More
This spring, after days of flulike symptoms and fever, a man arrived at the emergency room at the University of Vermont Medical Center.
More
The FINANCIAL Rapid lateral flow antigen testing (LFA) of traced contacts could stop a similar amount of onward COVID-19 transmission as the current two-week quarantining guidelines, according to preliminary modelling from the London School of Hygiene & Tropical Medicine (LSHTM).
More
Testing will still be a critical tool against COVID-19, even as vaccines are deployed against the disease, the head of the World Health Organization (WHO) said on Friday during his regular briefing on the crisis.
More
Making it easier for people and goods to cross borders has been clearly shown to provide widespread economic benefits. But countries on both sides need to be prepared to take advantage of the new opportunities created.
More
A migrant-inclusive approach to risk mitigation benefits everyone and leads to better development outcomes.
More
Experience in India shows a gradual and localized approach based on evidence allows for safer reopening of the economy and reduces infection rates.
More
The UK government has announced a “significant first step” in getting the AstraZeneca vaccine “approved for deployment.”
More